Russian COVID-19 vaccine approval imminent, source says Russian

Virology institute launches Russia's second COVID-19 vaccine human trial

CNN has learned that Russian Federation intends to approve the world's first coronavirus vaccine in less than two weeks, despite concerns about its safety, effectiveness and that the country has cut essential corners in development.

Stoffels said prior tests of this type of vaccine in other diseases found that a second shot significantly increases protection.

A separate state research facility in Moscow, the Gamaleya Institute, completed early human trials of an adenovirus-based vaccine earlier this month and expects to enter large-scale trials in August.

Although other companies are already enrolling patients in Phase 3 trials, vaccine experts say society will need more than one successful vaccine to ensure everyone has the chance to be immunized against the virus that causes COVID-19. "The trials began under the supervision of physician Dr Ajit Pratap Singh and gynaecologist and obstetrician Dr Sona Ghosh and the vaccine has been administered to 9 volunteers so far", Chief Administrative Officer of the hospital, Venketesh Chaturvedi said. Officials reported they are targeting August 10 or even earlier for the approval.

"The Ministry of Health in Russian Federation is following all necessary strict procedures".

The press service of the Russian Direct Investment Fund (RDIF), which is coordinating and funding Russia's vaccine development efforts, declined to comment, but its head, Kirill Dmitriev, has denied that Russia's vaccine push is compromising safety. "No corners are being cut", Dmitriev said on Tuesday.

Following the study, a Phase 1/2a first-in-human clinical trial of the vaccine candidate has now commenced in healthy volunteers in the United States and Belgium.

"Just as Sputnik was the result of very talented Russian scientists. our vaccine research is based on the work of great Russian scientists", he said.

Following allegations from UK, Canada and the United States that hackers backed by Russian Federation were trying to steal Covid-19 vaccine and treatment research, the head of Russia's wealth fund said the deal showed that Moscow has no need to steal anything. The allegations have been denied by Moscow.

The drug, if approved, would be the world's first coronavirus vaccine.

News about the planned approval of the vaccine comes as global confirmed cases of coronavirus hit 16,747,268.



Latest news

Governor Evers to issue mask mandate across Wisconsin
That death count is the 28th-highest in the country and the 35th highest per capita, at almost 16 deaths per 100,000 people. The new order also applies to outdoor bars and restaurants, except when people are eating or drinking.

New COVID-19 notification app rolls out in Ontario
The government describes it as an exposure notification app - not a contact-tracing app - as it does not track personal data. The more people who use it, the better it can trace, and therefore slow, the spread of the virus.

Rio Tinto profit falls but dividend increases amid ‘exceptional performance’
Shares of Rio Tinto PLC (LON: RIO ) gained 1.5% today after the mining giant reported better-than-expected first-half profit. Rio Tinto share price gained around 1.5% on the latest results.

Scientists solve mystery of Stonehenge megaliths origin
An open question remains about the two stones not sourced from West Woods, the origin of which could not be determined. It has helped solve the question of where the enormous stones of the world-famous monument are from.

Facebook surge leads tech megacaps higher, but Alphabet stumbles
The Dow Jones Industrial Average added 0.1 per cent to 26,345.83, while the broad-based S&P 500 climbed 0.3 per cent to 3,255.84. The results drove at least 27 Wall Street analysts to rethink their price targets of the giant, as reported by MarketWatch.

Other news